Literature DB >> 12139639

Actin-binding protein fascin expression in skin neoplasia.

Viktor N Goncharuk1, Jeffrey S Ross, J Andrew Carlson.   

Abstract

BACKGROUND: Fascin containing actin bundles provide mechanical support to cellular protrusions and stress fibers. In cancers, some malignant cells (e.g. subsets of breast and ovarian carcinomas) express fascin. In skin cancer, the role of fascin is unknown.
METHODS: Cases of 61 keratocytic neoplasms, 35 melanocytic neoplasms, nine extramammary Paget's disease (four with adenocarcinoma) and five sarcomas (angiosarcoma and atypical fibroxanthoma) were examined by immunohistochemistry, using monoclonal antihuman fascin antibody, clone 55 k-2 (Dako Corporation, Carpinteria, CA, USA).
RESULTS: Fascin labeled all sarcomas and all keratinocytic neoplasms except for pagetoid pattern Bowen's disease. The regions of most intense fascin labeling were seen in the basal cells of infiltrative tumor margins. A minority of Merkel cell carcinomas exhibited weak or absent immunoreactivity. All melanocytic nevi except for some junctional nests of dysplastic melanocytic nevi expressed fascin. However, pagetoid cells of melanoma in situ and epithelioid cells of invasive melanoma weakly expressed or did not express fascin, whereas melanoma cells exhibiting spindle cell morphologies labeled intensely with fascin. Lastly, all cells of extramammary Paget's disease and most associated adenocarcinomas cells did not or were faintly labeled by fascin antibodies. Decreased or absent fascin expression was significantly associated with skin cancers with a high risk for metastasis (e.g. melanoma) vs. those with a low risk (e.g. basal cell carcinoma) (24% vs. 100% with > 50% immunoreactivity; p = 0.0001, chi-squared test).
CONCLUSION: Fascin is expressed by skin tumors that locally infiltrate and replace surrounding tissues indicating a role for fascin in cell adhesion, cell motility and invasiveness. No or weak fascin expression is exhibited by cancers with pagetoid intraepidermal spread and by invasive tumors with a high risk of metastasis. Downregulation or loss of fascin's actin-bundling properties, probably associated with disorganization of cell-cell and cell-matrix contacts, may be a crucial step in the progression from locally invasive to widely disseminating cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139639     DOI: 10.1034/j.1600-0560.2002.290708.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  18 in total

1.  Expression of the actin stress fiber-associated protein CLP36 in the human placenta.

Authors:  Ulrich Miehe; Mamed Kadyrov; Peruka Neumaier-Wagner; Clemens Bartz; Werner Rath; Berthold Huppertz
Journal:  Histochem Cell Biol       Date:  2006-04-12       Impact factor: 4.304

2.  Fascin protein is critical for transforming growth factor β protein-induced invasion and filopodia formation in spindle-shaped tumor cells.

Authors:  Jianwei Sun; Huifang He; Yin Xiong; Shuang Lu; Junling Shen; Anna Cheng; Wei-Chiao Chang; Ming-Feng Hou; Johnathan M Lancaster; Minjung Kim; Shengyu Yang
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

3.  Differential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.

Authors:  Karim Rezaul; Jay Kumar Thumar; Deborah H Lundgren; Jimmy K Eng; Kevin P Claffey; Lori Wilson; David K Han
Journal:  Genes Cancer       Date:  2010-03

4.  Fascin expression in human embryonic, fetal, and normal adult tissue.

Authors:  Fa-Ren Zhang; Li-Hua Tao; Zhong-Ying Shen; Zhuo Lv; Li-Yan Xu; En-Min Li
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

5.  Expression of fascin in thyroid neoplasms: a novel diagnostic marker.

Authors:  Guang Chen; Fa-Ren Zhang; Jiang Ren; Li-Hua Tao; Zhong-Ying Shen; Zhuo Lv; Shi-Jiang Yu; Bing-Fei Dong; Li-Yan Xu; En-Min Li
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-15       Impact factor: 4.553

6.  miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.

Authors:  T Chiyomaru; H Enokida; S Tatarano; K Kawahara; Y Uchida; K Nishiyama; L Fujimura; N Kikkawa; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

7.  Fascin expression in colorectal carcinomas.

Authors:  Ismail Hakki Ozerhan; Nail Ersoz; Onder Onguru; Mustafa Ozturk; Bulent Kurt; Sadettin Cetiner
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

8.  Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.

Authors:  H Zhang; L Xu; D Xiao; J Xie; H Zeng; W Cai; Y Niu; Z Yang; Z Shen; E Li
Journal:  J Clin Pathol       Date:  2006-03-08       Impact factor: 3.411

9.  Rac1/Wave2/Arp3 Pathway Mediates Rat Blood-Brain Barrier Dysfunction under Simulated Microgravity Based on Proteomics Strategy.

Authors:  Ranran Yan; Huayan Liu; Fang Lv; Yulin Deng; Yujuan Li
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

10.  Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.

Authors:  Wei Gao; Chunming Zhang; Yan Feng; Ganggang Chen; Shuxin Wen; Hui Huangfu; Binquan Wang
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.